Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Identify where to invest first in crypto with clear criteria, risk guidance, and entry points designed for newcomers taking their initial step.
18,125 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Sandisk surged more than 3,000% in the past year, turning heads and raising questions about valuation and future move...
UniFirst stock rocketing higher again today follows news of a blockbuster offer from Cintas. This article breaks down...
June data reveal a surprising split: housing starts topped expectations while housing permits near cycle lows, hintin...
A JPMorgan-backed ETF focused on global dividend payers has a small asset base and a brief track record. Here’s what ...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...
Semiconductors retreat while Apple climbs, creating an unusual market dynamic. This article breaks down what the chip...
G-III Apparel faced a sharp slide after its latest earnings, signaling investor caution about licensing-heavy fashion...
When a top executive sells a sizable stake, investors pay attention. This article unpacks the CFO's 50,000-share move...
Gas-price swings touch every part of the economy and your portfolio. This guide breaks down what's driving those move...
As military spending climbs worldwide, select defense stocks poised benefit due to diversified portfolios, strong cas...